| 000 | 01728 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515230220.0 | ||
| 264 | 0 | _c20100920 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1931-8405 | ||
| 024 | 7 |
_a10.1089/aid.2009.0278 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPett, Sarah L | |
| 245 | 0 | 0 |
_aA novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection. _h[electronic resource] |
| 260 |
_bAIDS research and human retroviruses _cJun 2010 |
||
| 300 |
_a653-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCCR5 Receptor Antagonists |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesvirus 1, Human _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aZaunders, John | |
| 700 | 1 | _aBailey, Michelle | |
| 700 | 1 | _aMurray, John | |
| 700 | 1 | _aMacRae, Karen | |
| 700 | 1 | _aEmery, Sean | |
| 700 | 1 | _aCooper, David A | |
| 700 | 1 | _aKelleher, Anthony D | |
| 773 | 0 |
_tAIDS research and human retroviruses _gvol. 26 _gno. 6 _gp. 653-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/aid.2009.0278 _zAvailable from publisher's website |
| 999 |
_c19909630 _d19909630 |
||